Atrial cardiomyopathy in cardiac amyloidosis: clinical imaging and manifestations

Natasha Gorrie1,2,3, Paul Geenty4,5, Eleanor Rye6,7

  • 1Victor Chang Cardiac Research Institute, Darlinghurst, NSW, Australia. n.gorrie@victorchang.edu.au.

PubMed

Insights

Cardiac amyloidosis can cause atrial cardiomyopathy, impacting heart function and prognosis. This review highlights imaging and clinical outcomes related to this condition.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Amyloidosis Research

Background:

  • Cardiac amyloidosis is a progressive infiltrative disease causing significant heart complications.
  • Atrial abnormalities are often seen as secondary to ventricular dysfunction or arrhythmias.
  • Emerging evidence suggests primary atrial defects may occur in cardiac amyloidosis.

Purpose of the Study:

  • To review current evidence on atrial cardiomyopathy in cardiac amyloidosis.
  • To focus on the role of imaging in diagnosing and assessing atrial cardiomyopathy.
  • To correlate imaging findings with clinical outcomes in affected patients.

Main Methods:

  • Literature review of studies on cardiac amyloidosis and atrial cardiomyopathy.
  • Emphasis on diagnostic imaging modalities (e.g., echocardiography, cardiac MRI).
  • Analysis of studies reporting clinical outcomes and prognostic markers.

Main Results:

  • Atrial cardiomyopathy is increasingly recognized as a primary feature in cardiac amyloidosis.
  • Imaging plays a crucial role in detecting structural and functional atrial changes.
  • Atrial cardiomyopathy is associated with adverse clinical outcomes, including arrhythmias and heart failure.

Conclusions:

  • Atrial cardiomyopathy is an important, often under-recognized, component of cardiac amyloidosis.
  • Early identification through imaging may improve prognostic assessment.
  • Further research is needed to fully elucidate the mechanisms and therapeutic implications of atrial cardiomyopathy in this disease.

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
557
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
1.2K
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
493
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
952